Zydus Lifesciences has introduced ANVIMO ... ANVIMO is available in 240 mg and 480 mg dosages and has established bioequivalence with the reference drug. CMV infection is a critical complication ...

hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (FDA) to manufacture ibuprofen and famotidine tablets, 800 mg/26.6 mg. (USRLD: Duexis ...

Until now, innovator Letermovir 240 mg was imported at more than Rs.5 lakh per month, severely limiting access. With the launch of ANVIMO, Zydus has significantly reduced the cost by 91% of the ...

The stock of Zydus Lifesciences has been in a steady decline since August last year after facing resistance at ₹1,300. After witnessing some consolidation between ₹940 and ₹1,000 in December ...

Zydus Lifesciences share price will remain in focus on March 6 after the company received final approval from USFDA for Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg.

Zydus Lifesciences on Wednesday (February 26, 2025) said it is introducing a vaccine for protection against new strain of influenza virus. “The company is introducing country’s first flu ...

Zydus will carry out early-stage development. (Image Credits: Pixabay) Zydus Lifesciences Limited on Tuesday announced its focus on the development of a combination vaccine against shigellosis and ...

The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Pimavanserin tablets in strength of 10 mg, Zydus Cadila said in a statement. Zydus Cadila ...

Zydus Lifesciences Ltd received the “No Observation” from US Food and Drug Administration in its recently concluded surveillance inspection of its API (Active Pharmaceutical Ingredients) manuf ...

MG Windsor price range is Rs 13.50 lakh and Rs 15.50 lakh (ex-showroom) Battery-as-a-Service (BAAS) option reduces initial cost by Rs 3.5 lakh Battery warranty & car warranty: 8 years/1.6 lakh km ...

The pharmaceutical company has obtained final approval from the United States Food and Drug Administration (USFDA) to produce Dasatinib tablets in strengths of 20 mg, 50 mg, 70 mg, 80 mg ...

In particular, meloxicam 7.5 mg/day was associated with a lower incidence of gastrointestinal adverse events compared with diclofenac (13% vs 19%; p < 0.001) or piroxicam (10.3% vs 15.4% ...